1Ichikawa Y, Nakauchi T, Sato T, et al. Ultrasound diagnosis of uterine arteriovenous fistula associated with placental site trophoblastic tumor. Ultrasound Obstet Gynecol,2003, 21:606..608
4Newlands ES, Bagshawe KD, Begent RH, et al. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br J Obstet Gynaecol, 1991,98:550-557.
5Newlands ES, Mulholland PJ, Holden L, et al. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol,2000,18:854-859.
6Randall TC, Coukos G, Wheeler JE, et al. Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy. Gynecol Oncol, 2000, 76:115-117.
7Lurain JR. Advances in management of high-risk gestational trophoblastic tumors. J Reprod Med, 2002, 47:451-459.
8Moore-Maxwell CA, Robboy ST. Placental site trophoblastic tumor arising from antecedent molar pregnancy. Gynecol Oncol, 2004,92:708-712.
9Tsuji Y, Tsubamoto H, Hori M,et al. Case of PSTT treated with chemotherapy followed by open uterine tumor resection to preserve fertility. Gynecol Oncol, 2002,87:303-307.
10Horn LC, Goretzlehner U, Dirnhofer S. Placental site trophoblastic tumor(PSTT) initially misdiagnosed as cervical carcinoma. Pathol Res Pract, 1997,193:225-230.
